Jaffetilchin Investment Partners LLC lifted its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 13.8% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 4,364 shares of the healthcare conglomerate’s stock after purchasing an additional 530 shares during the quarter. Jaffetilchin Investment Partners LLC owned approximately 4.51% of UnitedHealth Group worth $855,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of UNH. Blue Chip Partners Inc. bought a new position in UnitedHealth Group during the second quarter worth $110,000. Bruderman Asset Management LLC bought a new position in UnitedHealth Group during the second quarter worth $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its stake in UnitedHealth Group by 433.3% during the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after acquiring an additional 520 shares in the last quarter. BDO Wealth Advisors LLC bought a new position in UnitedHealth Group during the second quarter worth $121,000. Finally, Acrospire Investment Management LLC boosted its stake in UnitedHealth Group by 130.7% during the second quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock worth $131,000 after acquiring an additional 400 shares in the last quarter. Institutional investors own 86.01% of the company’s stock.
UnitedHealth Group Inc (NYSE:UNH) opened at $228.73 on Friday. UnitedHealth Group Inc has a 12 month low of $156.09 and a 12 month high of $231.77. The firm has a market cap of $221,150.00, a price-to-earnings ratio of 25.99, a price-to-earnings-growth ratio of 1.54 and a beta of 0.66. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52.
The company also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Investors of record on Friday, December 1st were given a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.31%. The ex-dividend date of this dividend was Thursday, November 30th. UnitedHealth Group’s payout ratio is currently 34.09%.
In related news, Director Gail R. Wilensky sold 5,600 shares of the firm’s stock in a transaction dated Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the transaction, the director now directly owns 61,137 shares of the company’s stock, valued at $13,652,503.47. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Larry C. Renfro sold 22,598 shares of the firm’s stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the transaction, the chief executive officer now directly owns 195,314 shares in the company, valued at $43,310,879.50. The disclosure for this sale can be found here. Insiders have sold 34,630 shares of company stock worth $7,669,416 over the last three months. 0.89% of the stock is owned by insiders.
UNH has been the topic of several research analyst reports. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 target price on the stock in a research note on Thursday, September 21st. ValuEngine lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 5th. Sanford C. Bernstein reissued an “outperform” rating and set a $210.00 target price on shares of UnitedHealth Group in a research note on Tuesday, October 10th. Jefferies Group increased their target price on shares of UnitedHealth Group from $215.00 to $225.00 and gave the stock a “buy” rating in a research note on Friday, October 13th. Finally, BMO Capital Markets initiated coverage on shares of UnitedHealth Group in a research note on Monday, October 16th. They set an “outperform” rating and a $250.00 target price on the stock. Three equities research analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the stock. UnitedHealth Group has a consensus rating of “Buy” and a consensus target price of $226.74.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
What are top analysts saying about UnitedHealth Group? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for UnitedHealth Group and related companies.